Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,500
Closed -$249K 52
2024
Q4
$249K Buy
2,500
+700
+39% +$72.2K 0.23% 40
2024
Q3
$204K Buy
+1,800
New +$214K 0.13% 39
2024
Q2
Sell
-1,900
Closed -$251K 120
2024
Q1
$251K Sell
1,900
-4,200
-69% -$518K 0.1% 100
2023
Q4
$665K Buy
6,100
+2,900
+91% +$301K 0.24% 63
2023
Q3
$329K Sell
3,200
-8,220
-72% -$886K 0.15% 99
2023
Q2
$1.32M Buy
11,420
+4,240
+59% +$481K 0.32% 81
2023
Q1
$764K Buy
7,180
+630
+10% +$68K 0.15% 110
2022
Q4
$727K Sell
6,550
-1,940
-23% -$198K 0.14% 110
2022
Q3
$731K Sell
8,490
-1,230
-13% -$110K 0.15% 125
2022
Q2
$886K Sell
9,720
-2,680
-22% -$238K 0.15% 121
2022
Q1
$1.02M Buy
+12,400
New +$978K 0.17% 125

Other funds holding MRK

EHP Funds Inc's MRK Position: Q1 2025 in Review

EHP Funds Inc sold out of Merck (MRK) in Q1 2025, closing a stake of 2,500 shares — an estimated $249K sold.

EHP Funds Inc first reported a position in MRK in Q1 2022 and held it in 11 quarters. The position peaked at $1.32M in Q2 2023. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • EHP Funds Inc reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • EHP Funds Inc sold 2,500 Merck shares in Q1 2025, an estimated $249K.
  • EHP Funds Inc first reported a position in Merck in Q1 2022 and held it in 11 quarters.
  • EHP Funds Inc's Merck position peaked at $1.32M in Q2 2023.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on EHP Funds Inc's 13F filing for Q1 2025, filed 15 May 2025.